Dallas, TX -- (SBWIRE) -- 03/05/2011 -- There are currently over 23.6 million people in the U.S., or almost 8% of the population who have diabetes. The diabetes market is expected to show substantial growth due to the obesity epidemic in the U.S., now becoming known as diabesity. This report covers the U.S. Market for Diabetes Monitoring, Treatment and Drug Delivery, which includes:
Blood glucose diagnosis and monitoring including traditional blood glucose monitors
Continuous glucose monitoring systems (CGM),
Blood glucose test strips
Lancets and lancing devices
This market also includes the markets for insulin and insulin delivery devices including syringes, pens, pumps and jet injectors as well as oral anti-diabetic drugs.
Over the forecast period, the U.S. market for diabetes drugs, devices and monitoring systems is expected to grow at double-digit rates, reaching a value of over $55 billion by 2016. The market for insulin will grow over 18% in 2009, while continuous glucose monitoring systems will see growth of 48%. This report provides a comprehensive analysis of the blood glucose monitoring, insulin delivery and antidiabetic drug markets.
Within the diabetic devices market, companies such as Abbott, Bayer, Eli Lilly, Lifescan, Medtronic and Roche lead the market. This report also covers the insulin market as well as oral and injectable antidiabetic drugs. Oral drugs are estimated to see double-digit growth through 2016, with companies such as Amylin, Bristol-Myers, Squibb, GlaxoSmithKline, Merck & Co., Novo Nordisk, Pfizer and Takeda leading the market. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2016, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.
Buy Now: Market Research
Browse All: Drug Delivery U.S. Market
Browse All: Drug Delivery Market
U.S. Market for Diabetes Monitoring, Treatment and Drug Delivery 2010
http://www.reportsnreports.com/reports/18577-us-market-for-diabetes-monitoring-treatment-and-drug-delivery-.html
Related Reports
Drug Delivery Markets Implantable Injectable and Needle Free Delivery Systems
Drug Delivery Markets Oral Delivery
Global Injectable Drug Delivery Market (2010 – 2015)
BRIC Diabetes Drugs Market (2010-2015) in Brazil, Russia, India, China
China medical diagnosis, monitoring and treatment equipment manufacturing industry, 2010
Prostate Cancer – US Drug Forecasts and Treatment Analysis to 2020
Colorectal Cancer – US Drug Forecasts and Treatment Analysis to 2020
Innovations in Oral Solid Drug Delivery: Advances in nanotechnology, controlled formulations & peptide delivery
2010 U.S. Sewage Treatment Facilities Industry Report
2010 U.S. Waste Treatment & Disposal Industry Report
About ReportsnReports
ReportsnReports houses a comprehensive online library of more than 50,000 reports, in-depth market research studies of 5000+ micro markets, and 25 industry specific websites. The reports are analytically and statistically rich, and offer a comprehensive view of the dynamic market scenario across the globe. Our client list boasts of many eminent publishers of such reports from across the world. As a third-party reseller of market research reports, we employ various marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques, in order to generate better revenues for our clients, entailing positive and robust results.
Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website:http://www.reportsnreports.com
http://reportsnreports.wordpress.com/